Dr. Michelle Rhyu has twenty years of experience representing life sciences companies, with a primary focus on high-stakes patent, contract and trade secrets disputes in the pharmaceutical and biotechnology industries. She has extensive experience leading litigation and trial teams, has argued at the US Court of Appeals for the Federal Circuit and has led briefing to the US Supreme Court. Michelle has litigated cases involving small molecule drug compounds, pharmaceutical formulations, monoclonal antibodies, biofuels, hormone receptors, gene expression technology and medical devices. She has experience with Hatch-Waxman litigation and the abbreviated regulatory pathway for biosimilars (BPCIA).

Download full bio